Synapse - Gary Schwartz

Results (63)

SN-38 is a potential targeted chemotherapeutic for dedifferentiated liposarcoma

Meeting Abstract

Angeles, C. V.; Ugras, S.; Gobble, R. M.; Decarolis, P.; Shum, D.; Ostrovnaya, I.; O'Connor, R.; Djaballah, H.; Schwartz, G. K.; Singer, S.
Journal of the American College of Surgeons (2010)

Fulltext@MSK | Save

IGF2 overexpression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting

Journal Article

Hajdu, M.; Singer, S.; Maki, R. G.; Schwartz, G. K.; Keohan, M. L.; Antonescu, C. R.
Journal of Pathology (2010)

Fulltext@MSK | Save

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

Journal Article

Barretina, J.; Taylor, B. S.; Banerji, S.; Ramos, A. H.; Lagos-Quintana, M.; Decarolis, P. L.; Shah, K.; Socci, N. D.; Weir, B. A.; Ho, A.; more...
Nature Genetics (2010)

Fulltext@MSK | Save

γ-secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity

Journal Article

Meng, R. D.; Shelton, C. C.; Li, Y. M.; Qin, L. X.; Notterman, D.; Paty, P. B.; Schwartz, G. K.
Cancer Research (2009)

Fulltext@MSK | Save

Use of the Notch signaling pathway to predict disease progression and distant recurrence-free survival in early stage colon cancer

Meeting Abstract

Meng, R. D.; Qin, L.; Shelton, C. C.; Gerald, W. L.; Barany, F.; Notterman, D.; Li, Y.; Paty, P. B.; Schwartz, G. K.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas

Journal Article

Matushansky, I.; Hernando, E.; Socci, N. D.; Matos, T.; Mills, J.; Edgar, M. A.; Schwartz, G. K.; Singer, S.; Cordon-Cardo, C.; Maki, R. G.
American Journal of Pathology (2008)

Fulltext@MSK | Save

Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells

Journal Article

Ambrosini, G.; Cheema, H. S.; Seelman, S.; Teed, A.; Sambol, E. B.; Singer, S.; Schwartz, G. K.
Molecular Cancer Therapeutics (2008)

Fulltext@MSK | Save

Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma

Journal Article

Singer, S.; Socci, N. D.; Ambrosini, G.; Sambol, E.; Decarolis, P.; Wu, Y.; O'Connor, R.; Maki, R.; Viale, A.; Sander, C.; more...
Cancer Research (2007)

Fulltext@MSK | Save

Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor

Journal Article

Guo, T.; Agaram, N. P.; Wong, G. C.; Hom, G.; D'adamo, D.; Maki, R. G.; Schwartz, G. K.; Veach, D.; Clarkson, B. D; Singer, S.; more...
Clinical Cancer Research (2007)

Fulltext@MSK | Save

Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1

Journal Article

Ambrosini, G.; Sambol, E. B.; Carvajal, D.; Vassilev, L. T.; Singer, S.; Schwartz, G. K.
Oncogene (2007)

Fulltext@MSK | Save